ストックスクリーナーアプリを入手
39.85
0.50%
0.20
前日終値:
$39.65
開ける：
$39.95
24時間の取引高:
868.83K
Relative Volume:
0.82
時価総額：
$8.57B
収益：
$1.97B
当期純損益:
$92.93M
株価収益率:
98.01
EPS:
0.4066
ネットキャッシュフロー:
$459.60M
1週間 パフォーマンス:
+0.48%
1か月 パフォーマンス:
+3.78%
6か月 パフォーマンス:
-14.36%
1年 パフォーマンス:
-9.88%
1日の値動き範囲:
$39.70
$40.11
1週間の範囲:
$39.35
$40.11
52週間の値動き範囲:
$37.74
$49.30
Qiagen Nv Stock (QGEN) Company Profile
QGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
39.85 | 8.57B | 1.97B | 92.93M | 459.60M | 0.4066 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Yahoo Finance
QIAGEN NV : Jefferies reiterates its Buy rating - Marketscreener.com
Qiagen N.V. (NYSE:QGEN) is a favorite amongst institutional investors who own 81% - Simply Wall St
Qiagen Manager Pledges Shares in Securities Lending Transaction - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
QGEN Stock Might Rise Following Partnership With Genomics England - MSN
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? - Yahoo Finance
Digital Genome Market to Witness Remarkable Growth with QIAGEN, GenomeMe Inc., NanoString Technologies - openPR
The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses - Yahoo Finance
Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B - Medical Device Network
Qiagen at TD Cowen Conference: Strategic Growth Plans Unveiled - Investing.com
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday -March 06, 2025 at 09:14 am EST - Marketscreener.com
Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection - GlobeNewswire Inc.
QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel -March 06, 2025 at 04:04 am EST - Marketscreener.com
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio - Business Wire
Market is not liking Qiagen's (NYSE:QGEN) earnings decline as stock retreats 4.7% this week - Simply Wall St
Analyzing Tevogen Bio (NASDAQ:TVGN) and Qiagen (NYSE:QGEN) - Defense World
QIAGEN Announces Managerial Transactions Involving Performance Stock Units - TipRanks
QIAGEN Announces Managerial Stock Transaction - TipRanks
Qiagen Announces Managerial Stock Unit Grant - TipRanks
Qiagen Announces Managerial Stock Transactions - TipRanks
Qiagen Announces Managerial Transaction Involving Restricted Stock Units - TipRanks
Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now - MSN
Relative Strength Alert For Qiagen - Nasdaq
10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey
BioMérieux: complaint lodged by German company Qiagen -March 03, 2025 at 05:57 am EST - Marketscreener.com
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing - sharewise
Qiagen Files Patent Infringement Complaint in Germany Against bioMerieux -March 03, 2025 at 05:02 am EST - Marketscreener.com
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology - Nasdaq
What is Zacks Research’s Estimate for Qiagen Q1 Earnings? - Defense World
Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property -March 03, 2025 at 01:04 am EST - Marketscreener.com
Zacks Research Issues Negative Estimate for Qiagen Earnings - Defense World
Zacks Research Forecasts Qiagen's Q4 Earnings (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Reaches New 12-Month LowWhat's Next? - MarketBeat
Qiagen (NYSE:QGEN) Receives Average Rating of “Hold” from Brokerages - Defense World
Qiagen stock touches 52-week low at $38.48 amid market shifts - Investing.com
Qiagen stock touches 52-week low at $38.48 amid market shifts By Investing.com - Investing.com South Africa
Qiagen N.V.: Some Clarity Needed Before Buying The Dip (NYSE:QGEN) - Seeking Alpha
Genetic Testing Market Future Business Opportunities - openPR
AlphaValue/Baader Europe Upgrades Qiagen to Buy, Trims PT -February 24, 2025 at 07:17 am EST - Marketscreener.com
Qiagen (NYSE:QGEN) Stock Rating Lowered by Baird R W - MarketBeat
Qiagen (NYSE:QGEN) Reaches New 1-Year LowHere's What Happened - MarketBeat
Qiagen (NYSE:QGEN) Rating Lowered to Neutral at Robert W. Baird - MarketBeat
Qiagen, Bio-Techne downgraded at Baird amid NIH funding concerns - MSN
QIAGEN NV : Berenberg remains its Buy rating -February 21, 2025 at 03:41 am EST - Marketscreener.com
QIAGEN-TCS 10-year Partnership Accelerates Digital Transformation - Tata Consultancy Services (TCS)
Baird Downgrades Qiagen N.V. (BIT:1QGEN) - Nasdaq
Baird Downgrades Qiagen N.V. (QGEN) - MSN
Baird Downgrades Qiagen N.V. (BRSE:QGEN) - Nasdaq
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.80%
0.71%
大文字化:
|
ボリューム (24 時間):